| ESAGX | FNFWX | ESAGX / FNFWX | |
| Total Expense Ratio | 1.02 | 0.69 | 148% |
| Annual Report Gross Expense Ratio | 2.04 | 0.69 | 296% |
| Fund Existence | 7 years | 6 years | - |
| Gain YTD | 26.036 | 16.477 | 158% |
| Front Load | 5% | N/A | - |
| Min. Initial Investment | 1000 | 250 | 400% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 1.04M | 90B | 0% |
| Annual Yield % from dividends | 1.32 | 1.15 | 115% |
| Returns for 1 year | 36.58 | 17.30 | 211% |
| Returns for 3 years | 93.16 | 54.15 | 172% |
| Returns for 5 years | 15.70 | 19.42 | 81% |
| Returns for 10 years | N/A | N/A | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| ICTTX | 18.15 | 0.50 | +2.83% |
| ICON Health and Information Tech Inv | |||
| TWAIX | 14.71 | 0.12 | +0.82% |
| Thrivent International Equity S | |||
| MGIAX | 48.80 | N/A | N/A |
| MFS International Intrinsic Equity A | |||
| FHCIX | 73.98 | N/A | N/A |
| Fidelity Advisor Health Care I | |||
| MNHCX | 26.41 | N/A | N/A |
| Manning & Napier Pro-Blend Max Term L | |||